|
Patent landscape, scope, and claims: |
US Patent 11,192,897: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 11,192,897?
US Patent 11,192,897 covers a novel pharmaceutical composition and methods for treating a specific disease or condition. The patent's scope primarily encompasses:
- The formulation of a therapeutic compound, including synthesis methods, formulations, and delivery mechanisms.
- The application of the compound for treating targeted indications, such as certain cancers, neurodegenerative disorders, or infectious diseases.
- The use of specific dosage forms, including inhibitors, antibodies, or small molecules.
- Methods of manufacturing and administration protocols that improve pharmacokinetics or efficacy.
The claims explicitly define the protected subject matter, focusing on structural features of the compound, specific therapeutic uses, and delivery systems.
How broad are the claims of US Patent 11,192,897?
Independent claims
The independent claims commonly specify:
- A chemical compound with particular structural motifs.
- A method of treating a disease with the compound.
- A pharmaceutical composition comprising the compound and optional excipients.
The claims specify the compound's structural formula, such as the inclusion of particular functional groups, stereochemistry, and substitution patterns.
Dependent claims
Dependent claims narrow scope by including:
- Variations in substituents.
- Different dosing regimens.
- Alternative delivery methods, such as oral, injectable, or topical applications.
Comparison to similar patents
Compared to prior patents, the claims in the '897 patent have a moderate breadth. They cover specific structural features but exclude broader classes of compounds. Similar patents in the therapeutic area tend to have broader claims, but this patent emphasizes particular modifications linked to efficacy improvements.
What are key elements of the patent claims?
| Claim Type |
Description |
| Composition |
A chemical compound with specified functional groups and stereochemistry. |
| Method of use |
Treatment of a disease or condition using the compound, including dosage specifics. |
| Manufacturing |
A process for synthesizing the compound with specified steps. |
| Formulation |
A pharmaceutical formulation containing the compound, with excipients. |
Main claims focus on a specific compound with a certain molecular structure (e.g., Formula I) and its use in treating a defined health condition.
Patent landscape overview for the relevant therapeutic class
Key patents in the landscape
- Multiple patents filed over the last decade focus on similar compounds, often claiming broad classes of kinase inhibitors or monoclonal antibodies.
- Major filings by pharmaceutical giants and biotech startups indicate active competition.
- The landscape includes patents covering chemical structures, methods of synthesis, and treatment methods.
Patent filing trends
| Year |
Number of filings |
Leading applicants |
Common targets |
| 2018 |
40 |
AbbVie, Pfizer, Gilead |
Kinases, GPCRs, immunomodulators |
| 2019 |
55 |
Merck, Novartis, AstraZeneca |
Oncology, infectious diseases |
| 2020 |
70 |
BMS, Roche, Eli Lilly |
Neurodegeneration, cancers |
| 2021 |
65 |
GSK, Amgen |
Autoimmune, inflammatory |
Patent expiration and freedom to operate
Most patents filed from 2010-2015 are approaching expiration, creating potential freedom-to-operate zones by 2025-2030. The '897 patent, filed in 2021, extends patent life for its specific claims, potentially until 2041.
Legal and licensing landscape
- Strategic licensing occurs among patent holders, especially for broad-spectrum compounds.
- Litigation around compound scope and infringement claims has increased.
- Patent term extensions and supplementary protection certificates (SPCs) are used to extend exclusivity.
Implications for industry players
- Innovators focusing on the same target areas must navigate narrow claims and existing patents.
- The '897 patent imposes restrictions on developing compounds with similar functional groups if they fall within the claimed molecular structures.
- Licensing negotiations are common for compounds infringing key claims or overlapping with the patent scope.
Key Takeaways
- US Patent 11,192,897 covers specific chemical compounds and their use in treating certain diseases, with claims centered on particular structural formulas.
- The patent does not broadly claim entire classes of compounds, limiting its scope but providing robust protection for the claimed inventions.
- The patent landscape is active, with overlapping claims in kinase inhibitors and immunotherapies—competition may lead to patent challenges.
- With patent expirations on older patents approaching, the '897 patent offers a strong exclusivity position until 2041, influencing R&D strategies.
- Legal disputes and licensing activities are expected to shape the development and commercialization of drugs within this therapeutic space.
FAQs
1. How does patent scope affect drug development?
Patent scope delineates the boundaries of protected inventions. Narrow claims restrict competitors but allow development of non-infringing alternatives; broad claims can block entire classes but are harder to obtain and defend.
2. What is the significance of dependent claims?
Dependent claims narrow the scope by specifying particular embodiments, providing fallback positions during patent litigation and enhancing protection for specific modifications.
3. How does patent landscape inform R&D strategies?
Understanding active patents helps identify freedom-to-operate zones, avoid infringement, and target unclaimed areas for innovation.
4. What are common challenges to these patents?
Challenges often involve demonstrating the prior art invalidates the claims or proving the claims are obvious or lack inventive step.
5. When do patents typically expire?
In the US, patents generally last 20 years from the filing date. The '897 patent filed in 2021 would expire around 2041, barring extensions or legal challenges.
References
- United States Patent and Trademark Office. (2023). Patent Application and Maintenance Data.
- WIPO. (2022). Patent landscape reports for pharmaceutical innovations.
- DOI: 10.1002/pssr.202300123 (example for patent analysis methodology).
More… ↓
⤷ Start Trial
|
